Understanding Drug Test Panels and Cutoff Levels
Ask most buyers what a drug test detects and they will name a panel count. That answers only half the question. The panel says which analytes the device screens for; the cutoff level says how much of a substance has to be present before the result flips to non-negative. The cutoff is what quietly decides whether a borderline specimen reads positive or negative.
This guide explains what a panel is, how cutoff levels work, why SAMHSA cutoffs matter, and how to choose a configuration that fits your population.
What a panel is
A panel is the list of substances a device screens for. A 5-panel typically covers the classic drugs of abuse; larger panels add benzodiazepines, buprenorphine, methadone, oxycodone, fentanyl, and others. Each analyte on the panel has its own antibody and its own cutoff. More analytes mean broader coverage and higher cost per device.
What a cutoff level is, and why it decides the result
The cutoff is the concentration, usually in nanograms per milliliter, at which a screen reports non-negative. Below it, the result reads negative even if a trace is present; at or above it, the result flags. The same specimen can read negative on a high cutoff and non-negative on a lower one, which is why the cutoff is not a technicality, it is the definition of a positive for your program.
Why SAMHSA cutoffs matter
SAMHSA publishes standardized initial-screen and confirmatory cutoff levels used in federally regulated testing. Aligning to SAMHSA cutoffs makes your results comparable across sites and defensible in regulated contexts, and it is the expected baseline for most workplace programs. Some clinical and pain-management settings deliberately use lower cutoffs to detect at lower concentrations, which is a valid choice as long as it is documented and consistent.
Screen cutoff versus confirmation cutoff
- •The initial screen cutoff is the threshold on the onsite immunoassay device.
- •The confirmation cutoff is the threshold the laboratory uses on GC-MS or LC-MS, and it is often lower and analyte-specific.
- •A specimen can screen non-negative and then confirm negative if the specific substance is below the confirmation cutoff, which is normal and expected.
Choosing the right configuration
Match the panel to the substances your population actually uses, and match the cutoff to your program's requirements: SAMHSA-aligned for workplace and regulated testing, and documented lower cutoffs only where clinical need justifies it. Standardize the configuration across sites so results stay comparable and staff training stays simple.
Request wholesale pricing →FAQ
What is a cutoff level on a drug test?
The cutoff is the concentration at which a result reports non-negative. Below the cutoff a specimen reads negative even if a trace is present; at or above it the result flags. The cutoff, not just the panel, determines whether a borderline specimen is positive or negative.
Why do SAMHSA cutoff levels matter?
SAMHSA publishes standardized cutoffs used in federally regulated testing. Aligning to them makes results comparable across sites and defensible in regulated and workplace contexts. Lower cutoffs can be used in some clinical settings when documented and applied consistently.
Source from a supplier that stands behind every lot.
CLIA-waived and FDA 510(k)-cleared devices, SAMHSA cutoff calibration, same-day U.S. shipping, and white-label fulfillment. Register your organization for instant wholesale access.
← All resources